Interim Extension of Validity of National Tuberculosis Control Program-Directly Observed Treatment Short-Course (NTP-DOTS) Facilities’ Certification 25 September 2020
Interim Guidelines on the Recording, Reporting, and Interpretation of Results from Xpert MTB/RIF Ultra (Xpert Ultra) Testing Under the National TB Control Program 24 August 2020
Advisory on the Temporary Suspension for Select Regions on Securing License to Operate for COVID-19 Testing Laboratories using GeneXpert Technique 2 August 2020
Updated Guidelines on Handling of Specimens for Tuberculosis Testing (Xpert MTB/Rif Assay and Smear Microscopy) in the Presence of the Coronavirus Disease (COVID 19) Community Transmission 15 June 2020
Reiteration of the Guidelines on Proper Management of Patients Started on Drug-Resistant TB (DR-TB) Treatment Experiencing Hepatotoxicity, Myelosuppression, Peripheral Neuropathy, and QTe Prolongation 5 June 2020
